Masahisa Katsuno

19.4k total citations · 2 hit papers
419 papers, 11.6k citations indexed

About

Masahisa Katsuno is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Masahisa Katsuno has authored 419 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Neurology, 155 papers in Cellular and Molecular Neuroscience and 153 papers in Molecular Biology. Recurrent topics in Masahisa Katsuno's work include Genetic Neurodegenerative Diseases (112 papers), Neurogenetic and Muscular Disorders Research (112 papers) and Amyotrophic Lateral Sclerosis Research (76 papers). Masahisa Katsuno is often cited by papers focused on Genetic Neurodegenerative Diseases (112 papers), Neurogenetic and Muscular Disorders Research (112 papers) and Amyotrophic Lateral Sclerosis Research (76 papers). Masahisa Katsuno collaborates with scholars based in Japan, United States and France. Masahisa Katsuno's co-authors include Gen Sobue, Fumiaki Tanaka, Hiroaki Adachi, Haruki Koike, Manabu Doyu, Hirohisa Watanabe, Makoto Minamiyama, Masahiro Iijima, Masahiro Waza and Yohei Iguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Masahisa Katsuno

394 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome secretion is a key pathway for clearance of pathological TDP-43

2016 288 citations Yohei Iguchi, Shinnosuke Takagi et al. Brain profile →
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease

2020 270 citations Hiroshi Nishiwaki, Mikako Ito et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masahisa Katsuno Japan	56	5.9k	4.9k	4.0k	2.6k	1.8k	419	11.6k
Akiyoshi Kakita Japan	56	4.2k 0.7×	5.4k 1.1×	3.0k 0.8×	1.6k 0.6×	2.2k 1.2×	439	12.3k
Daniel Offen Israel	59	5.4k 0.9×	2.5k 0.5×	3.1k 0.8×	2.0k 0.8×	1.4k 0.8×	211	11.5k
Kevin Talbot United Kingdom	66	5.3k 0.9×	6.9k 1.4×	2.1k 0.5×	5.0k 1.9×	1.5k 0.8×	240	12.5k
Dirk Troost Netherlands	59	4.4k 0.7×	3.0k 0.6×	2.5k 0.6×	2.9k 1.1×	1.6k 0.9×	197	11.3k
Gabriele Siciliano Italy	52	4.6k 0.8×	2.6k 0.5×	2.3k 0.6×	872 0.3×	2.2k 1.3×	429	10.1k
Philip Van Damme Belgium	54	3.6k 0.6×	6.6k 1.3×	1.8k 0.5×	3.3k 1.3×	1.9k 1.1×	232	10.3k
Mari Yoshida Japan	50	4.8k 0.8×	7.0k 1.4×	2.2k 0.5×	1.9k 0.7×	3.4k 1.9×	311	11.5k
Beisha Tang China	52	5.1k 0.9×	3.9k 0.8×	3.7k 0.9×	540 0.2×	1.8k 1.0×	548	10.9k
Hideki Mochizuki Japan	57	3.8k 0.7×	3.8k 0.8×	2.9k 0.7×	516 0.2×	1.8k 1.0×	436	11.4k
Jan H. Veldink Netherlands	56	2.8k 0.5×	7.2k 1.5×	1.4k 0.3×	3.8k 1.5×	1.1k 0.6×	201	9.9k

Countries citing papers authored by Masahisa Katsuno

Since Specialization

Citations

This map shows the geographic impact of Masahisa Katsuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahisa Katsuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahisa Katsuno more than expected).

Fields of papers citing papers by Masahisa Katsuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahisa Katsuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahisa Katsuno. The network helps show where Masahisa Katsuno may publish in the future.

Co-authorship network of co-authors of Masahisa Katsuno

This figure shows the co-authorship network connecting the top 25 collaborators of Masahisa Katsuno. A scholar is included among the top collaborators of Masahisa Katsuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahisa Katsuno. Masahisa Katsuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiryu‐Seo, Sumiko, Koji Wakatsuki, Yoshitaka Tashiro, et al.. (2025). Absence of the axon initial segment in sensory neuron enhances resistance to amyotrophic lateral sclerosis. Brain. 148(11). 4030–4044.

Kawabata, Kazuya, Florian Krismer, Mizuki Ito, et al.. (2025). Trajectories of Pontine Volume in Patients with Multiple System Atrophy. Movement Disorders. 40(7). 1369–1378. 1 indexed citations

Hirayama, Takehisa, Yuishin Izumi, Mitsuya Morita, et al.. (2024). Reliability study for the Japanese version of the Columbia Muscle Cramp Scale in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience. 13(1). 14–21.

Fukami, Yuki, Hisatoshi Hanamatsu, Jun‐ichi Furukawa, et al.. (2024). Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. 32(1). e70023–e70023. 1 indexed citations

Maesawa, Satoshi, Takahiko Tsugawa, Takafumi Tanei, et al.. (2024). Outcomes and Prognostic Factors of Magnetic Resonance-guided Focused Ultrasound Thalamotomy for Essential Tremor at 2-year Follow-up. Neurologia medico-chirurgica. 64(4). 137–146. 2 indexed citations

Annane, Djillali, Andreas Meisel, Masahisa Katsuno, et al.. (2024). P.053 Concomitant corticosteroid use in ravulizumab-treated adults with anti-AChR antibody-positive gMG: results from the CHAMPION MG open-label extension. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(s1). S30–S30. 1 indexed citations

Tsuboi, Takashi, et al.. (2024). Persistence Pays: Diagnosing Tuberculous Meningitis after 11 Negative Polymerase Chain Reaction Evaluations. Internal Medicine. 64(6). 931–936. 1 indexed citations

Senda, Joe, Keiichi Ito, Masanori Mizuno, et al.. (2023). Investigation of inpatient convalescent rehabilitation outcomes in branch atheromatous disease. Journal of Stroke and Cerebrovascular Diseases. 32(3). 106937–106937.

Vu, Tuan, Andreas Meisel, Renato Mantegazza, et al.. (2023). Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. Neurology and Therapy. 12(5). 1435–1438. 14 indexed citations

10.

Ikenaka, Kensuke, Yasuhiro Maeda, Yuji Hotta, et al.. (2022). Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology. 29(5). 1410–1416. 6 indexed citations

11.

Kiryu‐Seo, Sumiko, Yoshitaka Tashiro, Takeshi Yoshimura, et al.. (2022). Impaired disassembly of the axon initial segment restricts mitochondrial entry into damaged axons. The EMBO Journal. 41(20). e110486–e110486. 16 indexed citations

12.

Nishiwaki, Hiroshi, Mikako Ito, Tomonari Hamaguchi, et al.. (2020). Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease. Movement Disorders. 35(9). 1626–1635. 270 indexed citations breakdown →

13.

Bagarinao, Epifanio, Hirohisa Watanabe, Satoshi Maesawa, et al.. (2020). Identifying the brain's connector hubs at the voxel level using functional connectivity overlap ratio. NeuroImage. 222. 117241–117241. 17 indexed citations

14.

Yamashita, Taro, Mitsuharu Ueda, Haruki Koike, et al.. (2020). Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study. Neurology and Clinical Neuroscience. 8(5). 251–260. 4 indexed citations

15.

Ohyama, Ken, Haruki Koike, Rina Hashimoto, et al.. (2016). Intraepidermal nerve fibre density in POEMS (Crow-Fukase) syndrome and the correlation with sural nerve pathology. Journal of the Neurological Sciences. 365. 207–211. 1 indexed citations

16.

Tohnai, Genki, Hiroaki Adachi, Masahisa Katsuno, et al.. (2014). Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. Human Molecular Genetics. 23(13). 3552–3565. 30 indexed citations

17.

Kawagashira, Yuichi, Haruki Koike, Ken Ohyama, et al.. (2014). Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. Journal of the Neurological Sciences. 348(1-2). 67–73. 22 indexed citations

18.

Suzuki, Keisuke, Masahisa Katsuno, Haruhiko Banno, et al.. (2009). The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. Journal of Neurology Neurosurgery & Psychiatry. 81(5). 567–571. 20 indexed citations

19.

Iijima, Masahiro, Haruki Koike, Nobutaka Hattori, et al.. (2008). Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. Journal of Neurology Neurosurgery & Psychiatry. 79(9). 1040–1043. 71 indexed citations

20.

Katsuno, Masahisa, Chen Sang, Hiroaki Adachi, et al.. (2005). Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proceedings of the National Academy of Sciences. 102(46). 16801–16806. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact